Hoth Therapeutics, Inc. (RKTO )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol RKTO
- Company Hoth Therapeutics, Inc.
- Price $0.8
- Changes Percentage -11.78
- Change -0.1063
- Day Low $0.79
- Day High $0.86
- Year High $2.44
- Year Low $1.16
- Market Cap $44,988,148
- Price Avg 50 EMA (D) $0.73
- Price Avg 200 EMA (D) $1.11
- Exchange NASDAQ
- Volume 14,596,781
- Average Volume 2,044,466
- Open $0.86
- Previous Close $0.9
- EPS -0.9
- PE -2.37
- Earnings Announcement 1970-01-01 00:00:00
- Shares Outstanding $19,127,600
Company brief: HOTH THERAPEUTICS, INC. (RKTO )
- Healthcare
- Medical - Pharmaceuticals
- Robbie Knie
- http://www.hoththerapeutics.com
- US
- N/A
- 11-30--0001
- US44148G2049
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in Hoboken, NJ.